| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB110-87047SS | |||
| Azide and BSA Free | NBP2-80605 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44740 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-89207-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11617 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70360 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43140-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37327-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-97637SS | |||
| BSA Free | NBP1-97637-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56176SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-27336SS | |||
| Azide and BSA Free | NBP2-80800 | |||
![Western Blot: BTK Antibody (7F12H4) [NB110-87047] - Analysis of BTK expression in 2) Raji, 3) A431 whole cell lysates and 4) human tonsil tissue extract.](http://images.novusbio.com/fullsize/BTK-Antibody-7F12H4-Western-Blot-NB110-87047-img0009.jpg "Western Blot: BTK Antibody (7F12H4) [NB110-87047] - Analysis of BTK expression in 2) Raji, 3) A431 whole cell lysates and 4) human tonsil tissue extract.")
![Immunocytochemistry/Immunofluorescence: BTK Antibody (7F12H4) [NB110-87047] - The BTK antibody was tested in A431 cells against DyLight 488 (Green). Actin and nuclei were counterstained for Phalloidin (Red) and DAPI (Blue), respectively.](http://images.novusbio.com/fullsize/BTK-Antibody-7F12H4-Immunocytochemistry-Immunofluorescence-NB110-87047-img0010.jpg)
![Immunohistochemistry-Paraffin: BTK Antibody (7F12H4) [NB110-87047] - Immunohistochemical analysis of paraffin-embedded human lymph-node tissues (left) and human lymph follicle tissues (right), showing cytoplasmic and membrane localization using BTK mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/BTK-Antibody-7F12H4-Immunohistochemistry-Paraffin-NB110-87047-img0005.jpg)
![Western Blot: BTK Antibody (7F12H4) [NB110-87047] - Analysis of BTK expression in 1) truncated BTK recombinant protein and 2) K562 cell lysate.](http://images.novusbio.com/fullsize/BTK-Antibody-7F12H4-Western-Blot-NB110-87047-img0006.jpg)
![Immunohistochemistry: TLR7 Antibody (66H3) [DDX0500P-100] - IHC staining of human FFPE tonsil section(Vermi William courtesy)](http://images.novusbio.com/fullsize/TLR7-Antibody-66H3-Immunohistochemistry-DDX0500P-100-img0007.jpg "Immunohistochemistry: TLR7 Antibody (66H3) [DDX0500P-100] - IHC staining of human FFPE tonsil section(Vermi William courtesy)")
![Flow (Intracellular): TLR7 Antibody (66H3) [DDX0500P-100] - Intracellular FACS staining of a canine cell line with 66H3](http://images.novusbio.com/fullsize/TLR7-Antibody-66H3-Flow-Intracellular-DDX0500P-100-img0006.jpg)
![Immunohistochemistry: TLR7 Antibody (66H3) [DDX0500P-100] - huTLR7-transfected 293 cells stained.](http://images.novusbio.com/fullsize/TLR7-Antibody-66H3-Immunohistochemistry-DDX0500P-100-img0002.jpg)
![Immunohistochemistry: TLR7 Antibody (66H3) [DDX0500P-100] - IHC staining of humantonsil cryosection with 66H3](http://images.novusbio.com/fullsize/TLR7-Antibody-66H3-Immunohistochemistry-DDX0500P-100-img0004.jpg)
![Immunohistochemistry: TLR7 Antibody (66H3) [DDX0500P-100] - huTLR7-transfected 293 cellsstained with 66H3](http://images.novusbio.com/fullsize/TLR7-Antibody-66H3-Immunohistochemistry-DDX0500P-100-img0005.jpg)
![Flow (Intracellular): TLR7 Antibody (66H3) [DDX0500P-100] - Intracellular FACS stainingof human PBMC with 66H3](http://images.novusbio.com/fullsize/TLR7-Antibody-66H3-Flow-Intracellular-DDX0500P-100-img0003.jpg)
![Western Blot: CD79A Antibody (JCB117 + HM47/A9) - Azide and BSA Free [NBP2-34653] - Western Blot Analysis of human Raji cell lysate using CD79A Antibody (JCB117 + HM47/A9).](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-+-HM47-A9-Azide-and-BSA-Free-Western-Blot-NBP2-34653-img0002.jpg "Western Blot: CD79A Antibody (JCB117 + HM47/A9) - Azide and BSA Free [NBP2-34653] - Western Blot Analysis of human Raji cell lysate using CD79A Antibody (JCB117 + HM47/A9).")
![Immunocytochemistry/Immunofluorescence: CD79A Antibody (JCB117 + HM47/A9) - Azide and BSA Free [NBP2-34653] - Immunofluorescent staining of paraformaldehyde-fixed Raji cells. CD79A Antibody (JCB117 + HM47/A9) followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot (Red)](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-+-HM47-A9-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-34653-img0001.jpg)
![Immunohistochemistry-Paraffin: CD79A Antibody (JCB117 + HM47/A9) - Azide and BSA Free [NBP2-34653] - Formalin-fixed, paraffin-embedded human tonsil (20X) stained with CD79a MAb (JCB117 + HM47/A9).](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-+-HM47-A9-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-34653-img0004.jpg)
![Flow Cytometry: CD79A Antibody (JCB117 + HM47/A9) - Azide and BSA Free [NBP2-34653] - Flow Cytometric Analysis of Raji cells. CD79A Antibody (JCB117 + HM47/A9) followed by goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-+-HM47-A9-Azide-and-BSA-Free-Flow-Cytometry-NBP2-34653-img0003.jpg)
![Immunohistochemistry-Paraffin: CD79A Antibody (JCB117 + HM47/A9) - Azide and BSA Free [NBP2-34653] - Formalin-fixed, paraffin-embedded human tonsil (10X) stained with CD79a MAb (JCB117 + HM47/A9).](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-+-HM47-A9-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-34653-img0005.jpg)
![Immunohistochemistry-Paraffin: BTK Antibody [NBP1-89207] - Analysis in human tonsil and kidney tissues. Corresponding BTK RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/BTK-Antibody-Immunohistochemistry-Paraffin-NBP1-89207-img0011.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: BTK Antibody [NBP1-89207] - Analysis in human tonsil and kidney tissues. Corresponding BTK RNA-seq data are presented for the same tissues.")
![<b>Independent Antibodies Validation and Orthogonal Strategies Validation.</b>Western Blot: BTK Antibody [NBP1-89207] - Analysis using Anti-BTK antibody NBP1-89207 (A) shows similar pattern to independent antibody NBP1-89206 (B).](http://images.novusbio.com/fullsize/BTK-Antibody-Western-Blot-NBP1-89207-img0014.jpg)
![Immunocytochemistry/Immunofluorescence: BTK Antibody [NBP1-89207] - Staining of human cell line U-251 MG shows localization to vesicles. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/BTK-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-89207-img0007.jpg)
![Immunohistochemistry-Paraffin: BTK Antibody [NBP1-89207] - Staining of human lymph node shows strong membranous positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/BTK-Antibody-Immunohistochemistry-NBP1-89207-img0016.jpg)
![Immunohistochemistry-Paraffin: BTK Antibody [NBP1-89207] - Staining of human kidney shows no positivity in cells in tubules as expected.](http://images.novusbio.com/fullsize/BTK-Antibody-Immunohistochemistry-Paraffin-NBP1-89207-img0012.jpg)
![Immunohistochemistry-Paraffin: BTK Antibody [NBP1-89207] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/BTK-Antibody-Immunohistochemistry-Paraffin-NBP1-89207-img0013.jpg)
![Immunohistochemistry-Paraffin: BTK Antibody [NBP1-89207] - Staining of human tonsil shows strong membranous positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/BTK-Antibody-Immunohistochemistry-NBP1-89207-img0015.jpg)
![Western Blot: CD79A Antibody (IGA/1790R) [NBP2-54608] - Analysis of Raji cell lysate using CD79a Rabbit Recombinant Monoclonal Antibody (IGA/1790).](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1790R-Western-Blot-NBP2-54608-img0002.jpg "Western Blot: CD79A Antibody (IGA/1790R) [NBP2-54608] - Analysis of Raji cell lysate using CD79a Rabbit Recombinant Monoclonal Antibody (IGA/1790).")
![Immunocytochemistry/Immunofluorescence: CD79A Antibody (IGA/1790R) [NBP2-54608] - Immunofluorescence Analysis of Raji cells labeling CD79a with CD79A Antibody (IGA/1790R) The nuclear counterstain is Red Dot (Red)](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1790R-Immunocytochemistry-Immunofluorescence-NBP2-54608-img0004.jpg)
![Immunohistochemistry-Paraffin: CD79A Antibody (IGA/1790R) [NBP2-54608] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD79a Rabbit Recombinant Monoclonal Antibody (IGA/1790R).](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1790R-Immunohistochemistry-Paraffin-NBP2-54608-img0001.jpg)
![Flow Cytometry: CD79A Antibody (IGA/1790R) [NBP2-54608] - Flow Cytometric Analysis of Raji cells using CD79A Antibody (IGA/1790R).followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1790R-Flow-Cytometry-NBP2-54608-img0006.jpg)
![Protein Array: CD79A Antibody (IGA/1790R) [NBP2-54608] - Analysis of Protein Array containing more than 19,000 full-length human proteins using CD79A Antibody (IGA/1790R). Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (MAb) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD's) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD's) between the Z-score. S-score therefore represents the relative target specificity of a MAb to its intended target. A MAb is considered to specific to its intended target, if the MAb has an S-score of at least 2.5.](http://images.novusbio.com/fullsize/CD79A-Antibody-IGA-1790R-Protein-Array-NBP2-54608-img0005.jpg)
![Western Blot: CD5 Antibody (OTI7A7) [NBP2-02690] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD5 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CD5.](http://images.novusbio.com/fullsize/CD5-Antibody-OTI7A7-Western-Blot-NBP2-02690-img0003.jpg "Western Blot: CD5 Antibody (OTI7A7) [NBP2-02690] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD5 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CD5.")
![Immunocytochemistry/Immunofluorescence: CD5 Antibody (OTI7A7) [NBP2-02690] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY CD5.](http://images.novusbio.com/fullsize/CD5-Antibody-OTI7A7-Immunocytochemistry-Immunofluorescence-NBP2-02690-img0008.jpg)
![Immunohistochemistry-Paraffin: CD5 Antibody (OTI7A7) [NBP2-02690] - Staining of paraffin-embedded Human Kidney tissue using anti-CD5 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/CD5-Antibody-OTI7A7-Immunohistochemistry-Paraffin-NBP2-02690-img0007.jpg)
![Flow Cytometry: CD5 Antibody (OTI7A7) [NBP2-02690] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/CD5-Antibody-OTI7A7-Flow-Cytometry-NBP2-02690-img0002.jpg)
![Immunohistochemistry-Paraffin: CD5 Antibody (OTI7A7) [NBP2-02690] - Staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-CD5 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/CD5-Antibody-OTI7A7-Immunohistochemistry-Paraffin-NBP2-02690-img0004.jpg)
![Immunohistochemistry-Paraffin: CD5 Antibody (OTI7A7) [NBP2-02690] - Staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-CD5 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/CD5-Antibody-OTI7A7-Immunohistochemistry-Paraffin-NBP2-02690-img0005.jpg)
![Immunohistochemistry-Paraffin: CD5 Antibody (OTI7A7) [NBP2-02690] - Staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-CD5 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/CD5-Antibody-OTI7A7-Immunohistochemistry-Paraffin-NBP2-02690-img0006.jpg)
![Flow Cytometry: CD5 Antibody (OTI7A7) [NBP2-02690] - Analysis of Jurkat cells, using anti-CD5 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/CD5-Antibody-OTI7A7-Flow-Cytometry-NBP2-02690-img0001.jpg)
![Imaging Mass Cytometry: CD5 Antibody (OTI7A7) [NBP2-02690] - Human tonsil tissue, CD5 conjugated to Er167. IMC image submitted by a verified customer review.](http://images.novusbio.com/fullsize/nbp2-02690_mouse-cd5-mab-oti7a7-17720241044650.jpg)
![Flow Cytometry: TLR9 Antibody (eB72-1665) [NBP1-43140] - Analysis using the PE conjugate of NBP1-43140. Staining of non-transfected (left) and human CD289-transfected (right) HEK 293T cells with 1.0 ug of Rat IgG2a kappa Isotype Control PE (open histogram) or 1.0 ug of Anti-Human CD289 (TLR9) PE (filled histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/TLR9-Antibody-eB72-1665-Flow-Cytometry-NBP1-43140-img0006.jpg "Flow Cytometry: TLR9 Antibody (eB72-1665) [NBP1-43140] - Analysis using the PE conjugate of NBP1-43140. Staining of non-transfected (left) and human CD289-transfected (right) HEK 293T cells with 1.0 ug of Rat IgG2a kappa Isotype Control PE (open histogram) or 1.0 ug of Anti-Human CD289 (TLR9) PE (filled histogram). Total viable cells were used for analysis.")
![Flow Cytometry: TLR9 Antibody (eB72-1665) [NBP1-43140] - HEK 293 parent cells (left panel) and 293/hTLR9 transfected cells (right panel) were fixed and permeabilized and subsequently stained with either Anti-Rat IgG FITC alone (thin line) or with 1 micrograms of Anti-Human CD289 (TLR9) Purified followed by Anti-Rat IgG FITC (thick line).](http://images.novusbio.com/fullsize/TLR9-Antibody-eB72-1665-Flow-Cytometry-NBP1-43140-img0003.jpg)
![Flow Cytometry: TLR9 Antibody (eB72-1665) [NBP1-43140] - HEK 293 parent cells (left panel) and 293/hTLR9 transfected cells (right panel) were fixed and permeabilized and subsequently stained with either Anti-Rat IgG FITC alone (thin line) or with 1 micrograms of Anti-Human CD289 (TLR9) Purified followed by Anti-Rat IgG FITC (thick line).](http://images.novusbio.com/fullsize/TLR9-Antibody-eB72-1665-Flow-Cytometry-NBP1-43140-img0004.jpg)
![Western Blot: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Analysis using CD22 mouse mAb against L1210 (1), Hela (2), HEK293 (3), Jurkat (4), OCM-1 (5), A432 (6) and NIH/3T3 (7) cell lysate.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-2H1C4-Western-Blot-NBP2-37327-img0004.jpg "Western Blot: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Analysis using CD22 mouse mAb against L1210 (1), Hela (2), HEK293 (3), Jurkat (4), OCM-1 (5), A432 (6) and NIH/3T3 (7) cell lysate.")
![Immunocytochemistry/Immunofluorescence: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Immunofluorescence analysis of Hela cells using CD22 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-2H1C4-Immunocytochemistry-Immunofluorescence-NBP2-37327-img0005.jpg)
![Immunohistochemistry-Paraffin: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Analysis of cerebellum tissues using CD22 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-2H1C4-Immunohistochemistry-NBP2-37327-img0008.jpg)
![Flow Cytometry: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Analysis of Hela cells using CD22 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-2H1C4-Flow-Cytometry-NBP2-37327-img0006.jpg)
![Western Blot: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Analysis using CD22 mAb against human CD22 recombinant protein. (Expected MW is 37 kDa).](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-2H1C4-Western-Blot-NBP2-37327-img0002.jpg)
![Western Blot: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Analysis using CD22 mAb against HEK293 (1) and CD22 (AA: 621-725)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-2H1C4-Western-Blot-NBP2-37327-img0003.jpg)
![Immunohistochemistry-Paraffin: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Analysis of cervical cancer tissues using CD22 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-2H1C4-Immunohistochemistry-NBP2-37327-img0007.jpg)
![ELISA: Siglec-2/CD22 Antibody (2H1C4) [NBP2-37327] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-2H1C4-ELISA-NBP2-37327-img0001.jpg)
![Immunohistochemistry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Immunostaining of HEK 293 cells transfected with a human BCMA expression plasmid (left panel), or mock transfected (right panel). Method: 3 days after transfection of cells with the indicated constructs, cells were fixed with acetone or 4% formaldehyde for 5 min. at room temperature. Slides were blocked with normal IgG, and incubated for 1 hour with 5ug/ml MAb to BCMA (human) (Vicky-1) in 1% BSA in 1x PBS. After washes in PBS, samples were incubated with the secondary antibody for 1 hour, washed in PBS and revealed with StreptABComplex/HRP (Vector) and AEC.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Immunohistochemistry-NBP1-97637-img0007.jpg "Immunohistochemistry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Immunostaining of HEK 293 cells transfected with a human BCMA expression plasmid (left panel), or mock transfected (right panel). Method: 3 days after transfection of cells with the indicated constructs, cells were fixed with acetone or 4% formaldehyde for 5 min. at room temperature. Slides were blocked with normal IgG, and incubated for 1 hour with 5ug/ml MAb to BCMA (human) (Vicky-1) in 1% BSA in 1x PBS. After washes in PBS, samples were incubated with the secondary antibody for 1 hour, washed in PBS and revealed with StreptABComplex/HRP (Vector) and AEC.")
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Analysis using the PE conjugate of NBP1-97637. Staining of 10^6 U266 cells using BCMA (human), mAb (Vicky-1) (PE conjugate) at a concentration of 10ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0011.jpg)
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Detection of endogenous human BCMA with MAb to BCMA (human) (Vicky-1). Method: U266 cells (2x10^5) were incubated on ice for 30 min. with 0.2ug of MAb to BCMA (human) (Vicky-1) or an isotype control in 25ul FACS buffer (PBS, 5% fetal calf serum, 0.02% azide). The primary antibody was revealed with PAb to Rat IgG (R-PE) and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0006.jpg)
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Analysis using the FITC conjugate of NBP1-97637. Staining of 10^6 Jurkat cells using BCMA (human), mAb (Vicky-1) (FITC conjugate) at a concentration of 50ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0010.jpg)
![Immunocytochemistry/Immunofluorescence: CD19 Antibody (JF100-06) [NBP2-67229] - Staining CD19 in PC-3M cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CD19-Antibody-JF100-06-Immunocytochemistry-Immunofluorescence-NBP2-67229-img0005.jpg "Immunocytochemistry/Immunofluorescence: CD19 Antibody (JF100-06) [NBP2-67229] - Staining CD19 in PC-3M cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.")
![Immunohistochemistry-Paraffin: CD19 Antibody (JF100-06) [NBP2-67229] - Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-CD19 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CD19-Antibody-JF100-06-Immunohistochemistry-Paraffin-NBP2-67229-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: CD19 Antibody (JF100-06) [NBP2-67229] - Staining CD19 in 293T cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CD19-Antibody-JF100-06-Immunocytochemistry-Immunofluorescence-NBP2-67229-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CD19 Antibody (JF100-06) [NBP2-67229] - Staining CD19 in Hela cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CD19-Antibody-JF100-06-Immunocytochemistry-Immunofluorescence-NBP2-67229-img0002.jpg)
![Immunohistochemistry-Paraffin: CD19 Antibody (JF100-06) [NBP2-67229] - Analysis of paraffin-embedded human spleen tissue using anti-CD19 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CD19-Antibody-JF100-06-Immunohistochemistry-Paraffin-NBP2-67229-img0003.jpg)
![Western Blot: CD19 Antibody (JF100-06) [NBP2-67229] -Analysis of CD19 on different lysates with Rabbit anti-CD19 antibody at 1/1,000 dilution.Lane 1: Raji cell lysateLane 2: Daudi cell lysateLysates/proteins at 10 ug/Lane.Predicted band size: 61 kDaObserved band size: 90 kDaExposure time: 2 minutes;8% SDS-PAGE gel.Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:300,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp2-67229_rabbit-monoclonal-cd19-antibody-jf100-06-western-blot-1382024114350..jpg)
![Flow Cytometry: CD19 Antibody (JF100-06) [NBP2-67229] -Analysis of Daudi cells labeling CD19.Cells were fixed and permeabilized. Then stained with the primary antibody (1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/nbp2-67229_rabbit-monoclonal-cd19-antibody-jf100-06-flow-cytometry-138202411462..jpg)
![Flow Cytometry: CD19 Antibody (JF100-06) [NBP2-67229] -Analysis of Raji cells labeling CD19.Cells were fixed and permeabilized. Then stained with the primary antibody (1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/nbp2-67229_rabbit-monoclonal-cd19-antibody-jf100-06-flow-cytometry-1382024114721..jpg)
![Immunohistochemistry-Paraffin: TRAF-3 Antibody - Unpurified [NB100-56176] - Analysis of formalin fixed paraffin-embedded (FFPE) human tonsil using this at 1:4000 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Staining was performed by Histowiz.](http://images.novusbio.com/fullsize/TRAF-3-Antibody-Immunohistochemistry-Paraffin-NB100-56176-img0001.jpg "Immunohistochemistry-Paraffin: TRAF-3 Antibody - Unpurified [NB100-56176] - Analysis of formalin fixed paraffin-embedded (FFPE) human tonsil using this at 1:4000 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Staining was performed by Histowiz.")
![Western Blot: IL-21 Antibody (14k5H3) [NBP2-27336] - Analysis of IL-21. Full-length recombinant IL-21 protein probed with 1 ug/ml of IL-21 monoclonal antibody. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IL-21-Antibody-14k5H3-Western-Blot-NBP2-27336-img0002.jpg "Western Blot: IL-21 Antibody (14k5H3) [NBP2-27336] - Analysis of IL-21. Full-length recombinant IL-21 protein probed with 1 ug/ml of IL-21 monoclonal antibody. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")